413 results on '"Knop S"'
Search Results
2. Comoving-frame radiative transfer in arbitrary velocity fields -- II. Large scale applications
3. A new formal solution of the radiative transfer in arbitrary velocity fields
4. Analyzing SN2003Z with PHOENIX
5. General Relativistic Radiative Transfer
6. Steps for Solving the Transfer Equation for Arbitrary Flows in Stationary Spacetimes
7. Perioperativer Umgang mit Antikoagulation
8. Perioperativer Umgang mit immunsuppressiver Therapie
9. Perioperativer Umgang mit Antidiabetika
10. Perioperativer Umgang mit antitumoralen Medikamenten
11. Perioperativer Umgang mit Thrombozytenaggregationshemmern
12. Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma
13. Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma
14. IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
15. 1001MO Initial safety, pharmacokinetics, and anti-tumor activity data of TCER IMA401, a MAGEA4/8-directed half-life extended TCR bispecific, in phase I dose escalation
16. Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes
17. Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P)
18. S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON-ELIGIBLE PATIENTS WITH NDMM (AGMT-MM02 TRIAL)
19. P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
20. Results From The CC-220-MM-001 Dose-Expansion Phase Of Iberdomide Plus Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma
21. Clinical response to ibrutinib is accompanied by normalization of the T-cell environment in CLL-related autoimmune cytopenia
22. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients
23. Therapiekonzepte bei jüngeren Patienten mit multiplem Myelom
24. Das multiple Myelom
25. Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)
26. Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients with relapsed/refractory multiple myeloma (RRMM)
27. Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
28. Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial
29. Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
30. Fortschritte in der Behandlung von Patienten mit multiplem Myelom: Hochdosistherapie und Stammzelltransplantation
31. Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma
32. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
33. Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party
34. OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease
35. Poster session Friday 13 December - PM: 13/12/2013, 14: 00–18: 00Location: Poster area
36. Poster session Friday 13 December - PM: 13/12/2013, 14: 00–18: 00Location: Poster area
37. Oral Abstract sessionThe importance of cardiac imaging in systemic diseases: 12/12/2013, 08: 30–10: 00Location: Bursa
38. Poster Session: Right ventricular systolic function
39. P878Regional left ventricular function in patients with cardiac amyloidosis: a typical deformation pattern shown by speckle tracking imaging
40. Anti-EGFR antibody Cetuximab in refractory or relapsed multiple myeloma: Final results of a phase II clinical trial: V819
41. Blinatumomab (CD3/CD19 Bite® Antibody) results in a high response rate in patients with relapsed non-hodgkin lymphoma (NHL) including mantle cell lymphoma (MCL) and diffuse large B cell lymphoma (DLBCL): V646
42. Bortezomib, iv cyclophosphamide and dexamethasone (VCD) as induction therapy in newly diagnosed multiple myeloma: Update on the interim results with 300 patients of the German DSMM XIa trial: V333 - Best Abstract
43. Total Marrow Irradiation, Busulfan, and Cyclophosphamide Is Equivalent to Tandem Melphalan in Myeloma: A453
44. Extramedullary Disease in Multiple Myeloma: A Rare and Still Undefined Clinical Picture: A488
45. Disclosing the CXCR4 expression status in multiple myeloma by in vivo molecular imaging
46. Clinical activity of PAT-SM6 monoclonal antibody in advanced and extramedullary Multiple Myeloma: results from a phase I study and a single patient treatment use
47. Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making
48. A new case of Carney triad: gastrointestinal stromal tumours and leiomyoma of the oesophagus do not show activating mutations of KIT and platelet-derived growth factor receptor α
49. 1500P Radiochemotherapy with gemcitabine as a radiosensitizer in patients with soft tissue sarcomas
50. Phase I/II study with bendamustine hydrochloride in patients with multiple myeloma relapsing after high dose therapy and autologous stem cell transplantation: P716
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.